Comparing Budesonide vs Eohilia
Budesonide | Eohilia (budesonide) |
|
---|
Budesonide | Eohilia (budesonide) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Inflammatory Bowel Disease, Crohn's Disease, Asthma, Autoimmune Hepatitis, Asthma - Maintenance, Crohn's Disease - Maintenance, Immunoglobulin A Nephropathy, Crohn's Disease - Active... View more |
Prescription only
Prescribed for Eosinophilic Esophagitis. Eohilia may also be used for purposes not listed in this medication guide. |
Related suggestions Eosinophilic Esophagitis
|
|||||||||||||||
More about Budesonide | More about Eohilia (budesonide) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Budesonide has an average rating of 6.8 out of 10 from a total of 167 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 19% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Budesonide side effects |
View all Eohilia side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Budesonide prices |
View all Eohilia prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Entocort EC, Eohilia, Pulmicort Flexhaler, Pulmicort Respules, Tarpeyo, Uceris | Other budesonide brands include: Entocort EC, Pulmicort Flexhaler, Pulmicort Respules, Tarpeyo, Uceris | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
2.8 hours |
2.8 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 563 drugs are known to interact with Budesonide:
|
A total of 563 drugs are known to interact with Eohilia:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
October 02, 2001 |
February 09, 2024 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Tarpeyo
Tarpeyo (budesonide) is an oral, delayed-release, corticosteroid capsule that may be used to reduce ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Filspari
Filspari is used to slow kidney function decline in adults with primary immunoglobulin A ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Xolair
Xolair injection (omalizumab) is used to reduce the risk of severe food allergy reactions ...
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.